Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature
The combination of gemcitabine and cisplatin chemotherapy with durvalumab was proven to be an effective treatment approach for advanced GBC, with manageable adverse events. Further research is warranted to substantiate the effectiveness of the combined regimen in the context of GBC.
Authors
- Lan Xiang (ORCID: https://orcid.org/0000-0001-6595-2836)
- Kai Chen (ORCID: https://orcid.org/0000-0003-0912-2613)
- Feng Xu (ORCID: https://orcid.org/0000-0002-7750-7809)
- Zheng‐Rong Shi
- Xinlin Li (ORCID: https://orcid.org/0000-0003-1455-1682)
- Yuan Shi (ORCID: https://orcid.org/0009-0006-7340-6935)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2024-12-11
- DOI
- https://doi.org/10.4251/wjgo.v17.i1.98433
- Citations
- 3
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.72